Galactomannan in piperacillin-tazobactam: How much and to what extent?

被引:23
|
作者
Machetti, M
Furfaro, E
Viscoli, C
机构
[1] Natl Inst Canc Res, Infect Dis Unit, I-16132 Genoa, Italy
[2] Adv Biotechnol Ctr, Genoa, Italy
关键词
D O I
10.1128/AAC.49.9.3984-3985.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:3984 / 3985
页数:2
相关论文
共 50 条
  • [31] Vancomycin/Piperacillin-tazobactam Nephrotoxicity in the Critically Ill
    Kollef, Marin H.
    Juang, Paul
    Micek, Scott T.
    CLINICAL INFECTIOUS DISEASES, 2020, 70 (07) : 1520 - 1521
  • [32] Rationale and evidence for extended infusion of piperacillin-tazobactam
    Kaufman, Scott E.
    Donnell, Robert W.
    Hickey, W. Scott
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2011, 68 (16) : 1521 - 1526
  • [33] Piperacillin-tazobactam as alternative to carbapenems for ICU patients
    Pilmis, Benoit
    Jullien, Vincent
    Tabah, Alexis
    Zahar, Jean-Ralph
    Brun-Buisson, Christian
    ANNALS OF INTENSIVE CARE, 2017, 7
  • [34] Appropriate prescribing of piperacillin-tazobactam in a teaching hospital
    Fanny, V.
    Sneyers, B.
    Yombi, J. -C.
    Jonckeere, S.
    Belkhir, L.
    Briquet, C.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 990 - 990
  • [35] Sensitization phenotypes in immediate reactions to piperacillin-tazobactam
    Gallardo, Alicia
    Moreno, Esther M.
    Laffond, Elena
    Munoz-Bellido, Francisco J.
    Teresa Gracia-Bara, M.
    Macias, Eva M.
    Valle Campanon, M.
    de Arriba, Sonia
    Martin, Cristina
    Sobrino, Miriam
    Davila, Ignacio
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (09): : 3175 - 3177
  • [36] HYPERSENSITIVITY MYOCARDITIS ASSOCIATED WITH PIPERACILLIN-TAZOBACTAM USE
    Jafri, Firas
    Arif, Shahrukh
    Ashraf, Uzair
    CHEST, 2020, 158 (04) : 226A - 226A
  • [37] PIPERACILLIN-TAZOBACTAM TREATMENT FOR SEVERE INTRAABDOMINAL INFECTIONS
    LEGRAND, JC
    BASTIN, F
    BELVA, P
    CHASTEL, C
    RENAUX, J
    VANEUKEM, P
    ACTA CHIRURGICA BELGICA, 1995, 95 (03) : 162 - 165
  • [38] Reply to "Delayed hypersensitivity reactions to piperacillin-tazobactam"
    Gallardo, Alicia
    Moreno, Esther M.
    Laffond, Elena
    Munoz-Bellido, Francisco J.
    Teresa Gracia-Bara, M.
    Macias, Eva M.
    Valle Campanon, M.
    de Arriba, Sonia
    Martin, Cristina
    Sobrino, Miriam
    Davila, Ignacio
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (06): : 2549 - 2549
  • [39] We need to optimize piperacillin-tazobactam dosing in critically ill patients—but how?
    Menino Osbert Cotta
    Jason A. Roberts
    Jeffrey Lipman
    Critical Care, 20
  • [40] Piperacillin-Tazobactam Hypersensitivity: A Large, Multicenter Analysis
    Casimir-Brown, Rosamund Sara
    Kennard, Lucinda
    Kayode, Oyindamola Stephanie
    Siew, Leonard Q. C.
    Makris, Michael
    Tsilochristou, Olympia
    Chytiroglou, Evangelia
    Nakonechna, Alla
    Rutkowski, Krzysztof
    Mirakian, Rita
    Wagner, Annette
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (05): : 2001 - 2009